Burnett Patrick bought ARQT
February 27, 2026 · Form 4 insider transaction
Burnett Patrick bought 30,000 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderBurnett Patrick
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after127,401
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Constitute RSUs for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting, in which 25% of the RSUs vest annually on March 1, (the "Vesting Commencement Date"), of each year beginning March 1, 2027, subject to the Reporting Person's continued service to the Issuer.